Matthew D. Vesely

6PUBLICATIONS
41CO-AUTHORS
Innate immunityTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity.

Tianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng

|May 26, 2022
The CD8α-PILRα interaction maintains CD8+ T cell quiescence.

Linghua Zheng, Xue Han, Sheng Yao

|May 20, 2022
Cancer Immunoediting in the Era of Immuno-oncology.

Matthew M Gubin, Matthew D Vesely

|Jan 14, 2022
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma.

Alexander X Lozano, Aadel A Chaudhuri, Aishwarya Nene

|Mar 04, 2021
A Burned-Out CD8+ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy.

Miguel F Sanmamed, Xinxin Nie, Shruti S Desai

|Dec 13, 2019
PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus.

Xue Han, Matthew D Vesely, Wendy Yang

Pageof 1

Frequent Collaborators

3 joint publications

Xue Han

3 joint publications

Lieping Chen

2 joint publications

Miguel F Sanmamed

2 joint publications

Dallas B Flies